References
- Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518.
- Hattori T, Nishiyama H, Kato H, et al. Clinical value of procalcitonin for patients with suspected bloodstream infection. Am J Clin Pathol. 2014;141(1):43–51.
- Stocker M, Fontana M, El Helou S, et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97(2):165–174.
- Matera G, Quirino A, Giancotti A, et al. Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol. 2012;12:68.
- Liappis AP, Gibbs KW, Nylen ES, et al. Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res. 2011;60(2):203–207.
- Oludag T, Gode F, Caglayan E, et al. Value of maternal procalcitonin levels for predicting subclinical intra-amniotic infection in preterm premature rupture of membranes. J Obstet Gynaecol Res. 2014;40(4):954–960.
- Canpolat FE, Yiğit S, Korkmaz A, et al. Procalcitonin versus CRP as an early indicator of fetal infection in preterm premature rupture of membranes. Turk J Pediatr. 2011;53(2):180–186.
- Torbé A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007;2007:35782.
- Montagnana M, Lippi G, Albiero A, et al. Procalcitonin values in preeclamptic women are related to severity of disease. Clin Chem Lab Med. 2008;46(7):1050–1051.
- Gulec UK, Ozgunen FT, Guzel AB, et al. An analysis of C-reactive protein, procalcitonin, and D-dimer in pre-eclamptic patients. Am J Reprod Immunol. 2012;68(4):331–337.
- Can M, Sancar E, Harma M, et al. Inflammatory markers in preeclamptic patients. Clin Chem Lab Med. 2011;49(9):1469–1472.
- Kuyumcuoglu U, Kangal K, Guzel AI, et al. Clinical significance of procalcitonin in cervico-vaginal secretions of women with preterm rupture of membranes. Clin Exp Obstet Gynecol. 2010;37(4):319–321.
- Torbé A, Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes? J Obstet Gynaecol Res. 2005;31(5):464–470.
- Plonka T, Bilar M, Sipak-Szmigiel O, et al. Concentration of procalcitonin in maternal blood, amniotic fluid and in umbilical cord blood as an indicator of neonatal infection. Med Wieku Rozwoj. 2006;10(4):1043–1053.
- Apuzzio J, Chan Y, Al-Khan A, et al. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery. J Matern Fetal Neonatal Med. 2004;15(5):313–317.
- Dulay AT, Buhimschi IA, Zhao G, et al. Compartmen-talization of acute phase reactants interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine. 2015;76(2):236–243.
- Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin-influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem. 1997;35(8):597–601.